Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

On September 28, 2020 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, reported that management will present at the following investor conferences (Press release, Sangamo Therapeutics, SEP 28, 2020, View Source [SID1234567680]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Gene Therapy / Editing Summit
Thursday, October 1st at 12:00 pm Eastern Time
Chardan Genetic Medicines Conference
Monday, October 5th at 8:00 a.m. Eastern Time
Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.